Bio Ascend – Developing your personal brand in GI Oncology – OncoDaily
Bio Ascend – Developing your personal brand in GI Oncology / Bio Ascend, cancer, OncoDaily, Oncology
Related Articles
Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms
Context.—. Standardized bone marrow reporting specifically for myelodysplastic syndromes/neoplasms (MDS) is currently lacking in the literature and much needed in practice.Objective.—. To propose a standardized…
An Evidence-Based Approach to Climate Change and Health
This JAMA Insights discusses the need to fully assimilate evidence from observed and projected effects of climate change on health and invest in developing and…
Rush to Crush Cancer
Exciting Update: Rush to Crush Ca ncer has moved to a new fundraising platform for 2025! This means that if you previously participated in one…
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study
PURPOSEHuman epidermal growth factor receptor 2 (HER2) alterations occur in many solid cancers, including non–small cell lung cancer (NSCLC). Beamion LUNG-1 (ClinicalTrials.gov identifier: NCT04886804) is…
Patient and care partner perspectives on treatment decision-making in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): a Global nLPHL One Working Group (GLOW) study
Published in Leukemia & Lymphoma (Ahead of Print, 2025)
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski / BCMA-negative myeloma, cancer, CAR-T therapy, Guixiang Wang, Jiahuan Chen, Jianqing Mi,
Reform MP Rupert Lowe hits back at party leadership after losing whip
MP accused of threatening party chair says dealing with leadership is like smashing his head against a brick wall
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study – PubMed
QuestionThe performance of artificial intelligence-based medical tools for prostate MRI has yet to be evaluated on multi-centre, multi-vendor data to assess generalisability. FindingsA dedicated AI…
Bar School: lecture @ the bar · Luma
Get ready to mix a little learning with your libations at Pub Ed! The bar isn’t your typical classroom setting—but this event will have a…
Dynamic responses to rejection in the transplanted human heart revealed through spatial transcriptomics
Allograft rejection following solid-organ transplantation is a major cause of graft dysfunction and mortality. Current approaches to diagnosis rely on histology, which exhibits wide diagnostic…
